Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

Commitments and Contingencies (Details Narrative)											1 Months Ended		3 Months Ended		27 Months Ended
Commitments and Contingencies (Details Narrative)	Feb. 28, 2017 USD ($)	Oct. 31, 2016 USD ($)	Oct. 13, 2016 USD ($)	Jul. 31, 2016 USD ($)	May 31, 2016 USD ($)	May 27, 2016 USD ($)	May 10, 2016 USD ($)	Feb. 16, 2016 USD ($)	Dec. 31, 2015 USD ($)	Jun. 03, 2015 USD ($)	Feb. 28, 2017 USD ($)	Jan. 31, 2017 Integer	Mar. 31, 2017 USD ($) $ / shares	Mar. 31, 2016 USD ($)	Mar. 31, 2017 USD ($) $ / shares	Dec. 31, 2016 USD ($) $ / shares
Loss contingency accrual, payments													$ 625,000
Common stock, par value \| $ / shares													$ 0.01		$ 0.01	$ 0.01
Severance costs									$ 3,700,000				$ 1,100,000
General and administrative expense													1,522,000	$ 2,816,000
Employee Severance [Member]
Restructuring Reserve																$ 3,100,000
Restructuring and Related Activities, Number of Former Employees Agreed to Settle Severance Obligations \| Integer												5
Restructuring and Related Activities, Percentage of Severance Obligations to be Paid to Former Employees												35.00%
Payments for Restructuring											$ 1,000,000
Reversal expenses											2,000,000
General and administrative expense											1,500,000
General and administrative expense, discontinued operations											$ 500,000
Continuing Operations [Member]
Severance costs													500,000
Discontinued Operations [Member]
Severance costs													50,000
Continuing Operations [Member] \| Employee Severance [Member]
Restructuring Reserve																2,200,000
Discontinuing Operations [Member] \| Employee Severance [Member]
Restructuring Reserve																$ 900,000
Companys Counter-Claim Against Prolias [Member]
Litigation settlement, amount			$ 500,000					$ 500,000
Notes issued										$ 1,000,000
Loss contingency, damages sought, value			621,236					636,053		$ 500,000
Loss contingency damages sought, value, attorney fees			$ 390,769
Litigation Settlement Amount, Interest, Per Diem								$ 137
Swann vs. Akorn, Inc, and Interpace Diagnostics Group, Inc [Member]
Loss contingency, damages sought, value						$ 300,000
Swann vs. Akorn, Inc, and Interpace Diagnostics Group, Inc [Member] \| Settlement Letter [Member]
Loss contingency, damages sought, value							$ 3,000
DOJ [Member]
Loss contingency, renegotiated, amount					$ 250,000
Loss contingency accrual, payments	$ 85,000	$ 85,000		$ 85,000
Settlement Agreement [Member]
Regulatory liabilities													$ 1,100,000		$ 1,100,000
Settlement Agreement [Member] \| RedPath [Member] \| Maximum [Member]
Litigation settlement, amount															$ 3,000,000